Lost password ?
<< Back to Equity Research
UNIMED
UNIMED STILL PENALISED BY FOUNDER’S LEGAL TROUBLE
Feb 17 - Our last paper on Unimed (Buy, Tunisia) was published over 8 months ago and since then, the situation has not much changed. The share is under-valued by the market, with a fundamental upside ...
Executive summary
Conflict of Interest
Pages 33
Language English
Publish on February 17, 2025
€ 500
VAT Exl.
You might be also interested by these reports :
Jan 07 AM
SIPHAT
Integration of 2026 estimates
Nov 20 PM
Gulf Pharmaceutical
A TP down after the exit of Planet Pharmacies
Nov 14 PM
Gulf Pharmaceutical
Slowly improving profitability
Nov 03 PM
Idea Kicker
JULPHAR, POISED FOR A COMEBACK
FIND A REPORT
CONCEPT
Each company is researched in depth using a structured robust and transparent process.

AlphaMena provides analyses based upon exhaustive and homogeneous information which allows to compare stocks geographically, sector-wise, and by thematic.

The analyses include actuarial as well as off balance-sheet data.
BloombergStarmineFactsetReutersCapital IQ